Delivery Order HHSN261201600015I-75N91018F00004
Award Date 9/5/18
Potential Completion Date 6/30/21
Potential Value $488K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute issued a delivery order to IIT Research Institute on July 27, 2016, with a ceiling value of $631,772, under the Toxicology of Drugs Developed for Cancer Patients IDIQ for reproductive toxicology studies in rats.</p> <p>Place of performance is Chicago, Illinois. The order runs from July 27, 2016, through March 31, 2018, and is priced on a cost-plus-fixed-fee basis. The work supports preclinical drug development evaluation for cancer therapeutics.</p>
- This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...
- The National Cancer Institute awarded a definitive cost-plus-fixed-fee contract to IIT Research Institute (IITRI), a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, for preclinical toxicology and pharmacology services supporting drug development for cancer, AIDS, and AIDS-related illnesses. The contract, awarded on April 1, 2004, carries a ceiling value of $159.3 million with an ultimate completion date of June 30, 2016, and will be performed...
- This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $2.4 million delivery order against the Toxicology of Drugs Developed for Cancer Patients master IDIQ contract to IIT Research Institute. Under this order, IIT Research Institute will provide toxicology services to support the preclinical development of EIF4A inhibitors rocaglamide and didesmethylrocaglamide from September 2020 through September 2023 in...
- This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas. IITRI has extensive experience providing these services to...
- This is a $2,561,491.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the IIT Research Institute, a non-profit research arm of the Illinois Institute of Technology. The contract supports preclinical drug testing services, including pharmacology, toxicology, and safety testing, to generate data for Investigational New Drug applications across therapeutic areas such as cancer, neurology, and...
- The National Cancer Institute awarded a $9.35 million cost-plus-fixed-fee contract to IIT Research Institute (IITRI) on April 1, 2022, for preclinical toxicology studies of large molecule drugs developed for cancer and other indications. The contract, which extends through March 31, 2029, will be performed in Chicago, Illinois. IITRI, a nonprofit contract research organization and subsidiary of Illinois Institute of Technology, will conduct comprehensive toxicological testing and safety...
- This is a $1,790,042.00 Delivery Order Contract awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology (IIT). The contract is for toxicology studies in mice and dogs administered MTX-531, which does not have a set-aside designation. IITRI is a leading preclinical contract research organization that specializes in providing drug development services to federal agencies like the NCI, NIAID, NINDS, and...